EUVIMEDEUVIMED entdecken
Crossref

Activatable Immunoprotease Nanorestimulator for Second Near-Infrared Photothermal Immunotherapy of Cancer

Mengke Xu, Chi Zhang, Shasha He iD, Cheng Xu iD, Xin Wei, Kanyi Pu iD

ACS Nano · 09.05.2023 · 17 (9) · 8183-8194

DOI: 10.1021/acsnano.2c12066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 01.05.2023. Verfasst von Mengke Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 70 Nanyang Drive, Singapore 637457, Singapore. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Nanoparticles. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Ministry of Education - Singapore, National Research Foundation Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photothermal immunotherapy is a combinational cancer therapy modality, wherein the photothermal process can noninvasively ablate cancer and efficiently trigger cancer immunogenic cell death to ignite antitumor immunity. However, cancer cells can resist the cytotoxic lymphocyte-mediated antitumor effect via expressing serine protease inhibitory proteins (serpins) to deactivate proteolytic immunoproteases. Herein, we report a smart polymer nanoagonist (SPND) with second near-infrared (NIR-II) phototherapeutic ablation and tumor-specific immunoprotease granzyme B (GrB) restimulation for cancer photothermal immunotherapy. SPND has a semiconducting polymer backbone grafted with a small-molecule inhibitor of serpinB9 (Sb9i) via a glutathione (GSH)-cleavable linker. Once in the tumor, Sb9i can be specifically liberated from SPND to inhibit serpinB9, restimulating the activity of GrB to enhance cancer immunotherapy. Moreover, SPND induces photothermal therapy for direct tumor ablation and immunogenic cancer cell death (ICD) under NIR-II photoirradiation. Therefore, such a smart nanoagonist represents a way toward combination photothermal immunotherapy (PTI).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsNanoparticlesHumansPhototherapyPhotothermal TherapyImmunotherapyCell Line, Tumor

Stichwörter der Autor:innen

cancer therapyimmunoprotease restimulationimmunotherapysecond near-infrared photothermal therapysemiconducting polymer nanoparticles

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 70 Nanyang Drive, Singapore 637457, Singapore.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, 59 Nanyang Drive, Singapore 636921, Singapore.

ORCID-Profile: Shasha He, Cheng Xu, Kanyi Pu

Förderung

  • Ministry of Education - Singapore
  • National Research Foundation Singapore

Zitieren

APA

Xu, M., Zhang, C., He, S., Xu, C., Wei, X., & Pu, K. (2023). Activatable Immunoprotease Nanorestimulator for Second Near-Infrared Photothermal Immunotherapy of Cancer. ACS Nano, 17(9), 8183-8194. https://doi.org/10.1021/acsnano.2c12066

Vancouver

Xu M, Zhang C, He S, Xu C, Wei X, Pu K. Activatable Immunoprotease Nanorestimulator for Second Near-Infrared Photothermal Immunotherapy of Cancer. ACS Nano. 2023;17(9):8183-8194. doi:10.1021/acsnano.2c12066

BibTeX
@article{Xu2023,
  author = {Xu, Mengke and Zhang, Chi and He, Shasha and Xu, Cheng and Wei, Xin and Pu, Kanyi},
  title = {Activatable Immunoprotease Nanorestimulator for Second Near-Infrared Photothermal Immunotherapy of Cancer},
  journal = {ACS Nano},
  year = {2023},
  volume = {17},
  number = {9},
  pages = {8183--8194},
  doi = {10.1021/acsnano.2c12066}
}
Kostenlos starten →